Cost-effectiveness of HIV Prevention Interventions: Estimates from Real-world Implementation Needed
Year: 2019
Type: article
Abstract: Despite important reductions in HIV-1 incidence in sub-Saharan Africa over the past decade, current projections suggest that UNAIDS epidemic control targets for 2020 will not be met [1]. The rapidly expanding toolkit of HIV-1 prevention methods – including risk and harm reduction interventions, voluntary medical male circumcision (VMMC), and antiretrovirals for treatment as prevention (TasP), prevention of mother-to-child transmission (PMTCT), and pre-exposure prophylaxis (PrEP) – arguably contains the components necessary, when delivered in combination, to curtail the epidemic substantially.
Source: EClinicalMedicine
Authors: Kathryn Peebles, Jared M. Baeten
Institution: University of Washington
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,500
OpenAlex ID: W2944623028
